Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Maureen Ross

Showing results (11-20 of 24) with videos related to

Pageof 3
Sort By:
Transplantation and Cellular Therapy|June 1, 2026
A Phase Ib Study of Efmarodocokin Alfa, an Interleukin-22 Agonist, in Combination with Standard of Care, in Patients Undergoing Allogeneic Hematopoietic Stem Cell TransplantationShukaib Arslan, Corey Cutler, Amin Alousi, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|May 29, 2014
Early versus late preemptive allogeneic hematopoietic cell transplantation for relapsed or refractory acute myeloid leukemiaGeorge L Chen, Hong Liu, Yali Zhang, et al.
Transplantation and Cellular Therapy|May 27, 2024
Outcomes of Human Leukocyte Antigen-Matched Related Donor and Haploidentical Allogeneic Hematopoietic Cell Transplantation Recipients by Immune Profiles of Recipients and DonorsMegan M Herr, Sophia R Balderman, Paul K Wallace, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|July 30, 2020
Low-Level Cytomegalovirus Antigenemia Promotes Protective Cytomegalovirus Antigen-Specific T Cells after Allogeneic Hematopoietic Cell TransplantationGeorge L Chen, Paul K Wallace, Yali Zhang, et al.
World Journal of Clinical Oncology|March 1, 2019
Impact of conditioning regimen on peripheral blood hematopoietic cell transplantMichael Burns, Anurag K Singh, Carrie C Hoefer, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|January 31, 2006
Consolidation with high-dose combination alkylating agents with bone marrow transplantation significantly improves disease-free survival in hormone-insensitive metastatic breast cancer in complete remission compared with intensive standard-dose chemotherapy aloneJames J Vredenburgh, David Coniglio, Gloria Broadwater, et al.
Bone Marrow Transplantation|June 23, 2019
Immune profiling in diffuse large B-cell lymphoma and mantle cell lymphoma patients treated with autologous hematopoietic cell transplantMegan M Herr, Pallawi Torka, Yali Zhang, et al.
Bone Marrow Transplantation|September 1, 2019
Correction: Immune profiling in diffuse large B-cell lymphoma and mantle cell lymphoma patients treated with autologous hematopoietic cell transplantMegan M Herr, Pallawi Torka, Yali Zhang, et al.
Transplantation and Cellular Therapy|July 5, 2026
System-Level Redesign of an Allogeneic Hematopoietic Cell Transplantation Program Associated with High 1-Year Survival and Reduced CostShernan G Holtan, Megan M Herr, Kanwal Mallhi, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|October 10, 2018
Reduced-Intensity Conditioning with Fludarabine, Melphalan, and Total Body Irradiation for Allogeneic Hematopoietic Cell Transplantation: The Effect of Increasing Melphalan Dose on Underlying Disease and ToxicityGeorge L Chen, Theresa Hahn, Gregory E Wilding, et al.
Pageof 3

Showing results (11-20 of 24) with videos related to

Sort By:
Pageof 3
Transplantation and Cellular Therapy|June 1, 2026
A Phase Ib Study of Efmarodocokin Alfa, an Interleukin-22 Agonist, in Combination with Standard of Care, in Patients Undergoing Allogeneic Hematopoietic Stem Cell TransplantationShukaib Arslan, Corey Cutler, Amin Alousi, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|May 29, 2014
Early versus late preemptive allogeneic hematopoietic cell transplantation for relapsed or refractory acute myeloid leukemiaGeorge L Chen, Hong Liu, Yali Zhang, et al.
Transplantation and Cellular Therapy|May 27, 2024
Outcomes of Human Leukocyte Antigen-Matched Related Donor and Haploidentical Allogeneic Hematopoietic Cell Transplantation Recipients by Immune Profiles of Recipients and DonorsMegan M Herr, Sophia R Balderman, Paul K Wallace, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|July 30, 2020
Low-Level Cytomegalovirus Antigenemia Promotes Protective Cytomegalovirus Antigen-Specific T Cells after Allogeneic Hematopoietic Cell TransplantationGeorge L Chen, Paul K Wallace, Yali Zhang, et al.
World Journal of Clinical Oncology|March 1, 2019
Impact of conditioning regimen on peripheral blood hematopoietic cell transplantMichael Burns, Anurag K Singh, Carrie C Hoefer, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|January 31, 2006
Consolidation with high-dose combination alkylating agents with bone marrow transplantation significantly improves disease-free survival in hormone-insensitive metastatic breast cancer in complete remission compared with intensive standard-dose chemotherapy aloneJames J Vredenburgh, David Coniglio, Gloria Broadwater, et al.
Bone Marrow Transplantation|June 23, 2019
Immune profiling in diffuse large B-cell lymphoma and mantle cell lymphoma patients treated with autologous hematopoietic cell transplantMegan M Herr, Pallawi Torka, Yali Zhang, et al.
Bone Marrow Transplantation|September 1, 2019
Correction: Immune profiling in diffuse large B-cell lymphoma and mantle cell lymphoma patients treated with autologous hematopoietic cell transplantMegan M Herr, Pallawi Torka, Yali Zhang, et al.
Transplantation and Cellular Therapy|July 5, 2026
System-Level Redesign of an Allogeneic Hematopoietic Cell Transplantation Program Associated with High 1-Year Survival and Reduced CostShernan G Holtan, Megan M Herr, Kanwal Mallhi, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|October 10, 2018
Reduced-Intensity Conditioning with Fludarabine, Melphalan, and Total Body Irradiation for Allogeneic Hematopoietic Cell Transplantation: The Effect of Increasing Melphalan Dose on Underlying Disease and ToxicityGeorge L Chen, Theresa Hahn, Gregory E Wilding, et al.
Pageof 3